Literature DB >> 21093314

Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients.

Christopher J Pannucci1, Steven H Bailey, George Dreszer, Christine Fisher Wachtman, Justin W Zumsteg, Reda M Jaber, Jennifer B Hamill, Keith M Hume, J Peter Rubin, Peter C Neligan, Loree K Kalliainen, Ronald E Hoxworth, Andrea L Pusic, Edwin G Wilkins.   

Abstract

BACKGROUND: The Venous Thromboembolism Prevention Study (VTEPS) Network is a consortium of 5 tertiary referral centers established to examine venous thromboembolism (VTE) in plastic surgery patients. We report our midterm analyses of the study's control group to evaluate the incidence of VTE in patients who receive no chemoprophylaxis, and validate the Caprini Risk Assessment Model (RAM) in plastic surgery patients. STUDY
DESIGN: Medical record review was performed at VTEPS centers for all eligible plastic surgery patients between March 2006 and June 2009. Inclusion criteria were Caprini score ≥3, surgery under general anesthesia, and postoperative hospital admission. Patients who received chemoprophylaxis were excluded. Dependent variables included symptomatic deep vein thrombosis (DVT) or pulmonary embolism (PE) within the first 60 postoperative days and time to DVT or PE.
RESULTS: We identified 1,126 historic control patients. The overall VTE incidence was 1.69%. Approximately 1 in 9 (11.3%) patients with Caprini score >8 had a VTE event. Patients with Caprini score >8 were significantly more likely to develop VTE when compared with patients with Caprini score of 3 to 4 (odds ratio [OR] 20.9, p < 0.001), 5 to 6 (OR 9.9, p < 0.001), or 7 to 8 (OR 4.6, p = 0.015). Among patients with Caprini score 7 to 8 or Caprini score >8, VTE risk was not limited to the immediate postoperative period (postoperative days 1-14). In these high-risk patients, more than 50% of VTE events were diagnosed in the late (days 15-60) postoperative period.
CONCLUSIONS: The Caprini RAM effectively risk-stratifies plastic and reconstructive surgery patients for VTE risk. Among patients with Caprini score >8, 11.3% have a postoperative VTE when chemoprophylaxis is not provided. In higher risk patients, there was no evidence that VTE risk is limited to the immediate postoperative period.
Copyright © 2011 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093314      PMCID: PMC3052944          DOI: 10.1016/j.jamcollsurg.2010.08.018

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  46 in total

1.  A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project.

Authors:  Giancarlo Agnelli; Giorgio Bolis; Lorenzo Capussotti; Roberto Mario Scarpa; Francesco Tonelli; Erminio Bonizzoni; Marco Moia; Fabio Parazzini; Romina Rossi; Francesco Sonaglia; Bettina Valarani; Carlo Bianchini; Gualberto Gussoni
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

2.  VTE prophylaxis in aesthetic surgery patients.

Authors:  David Green
Journal:  Aesthet Surg J       Date:  2006 May-Jun       Impact factor: 4.283

3.  The efficacy of prophylactic low-molecular-weight heparin to prevent pulmonary thromboembolism in immediate breast reconstruction using the TRAM flap.

Authors:  Eun Key Kim; Jin Sup Eom; Sei Hyun Ahn; Byung Ho Son; Taik Jong Lee
Journal:  Plast Reconstr Surg       Date:  2009-01       Impact factor: 4.730

4.  Hematoma risk should not preclude the use of venous thromboembolism prophylaxis.

Authors:  Christopher J Pannucci; Edwin G Wilkins
Journal:  Aesthet Surg J       Date:  2009 Jul-Aug       Impact factor: 4.283

5.  Do cosmetic surgeons consider estrogen-containing drugs to be of significant risk in the development of thromboembolism?

Authors:  R L Johnson; S J Hemington-Gorse; S K Dhital
Journal:  Aesthetic Plast Surg       Date:  2008-04-30       Impact factor: 2.326

6.  A validation study of a retrospective venous thromboembolism risk scoring method.

Authors:  Vinita Bahl; Hsou Mei Hu; Peter K Henke; Thomas W Wakefield; Darrell A Campbell; Joseph A Caprini
Journal:  Ann Surg       Date:  2010-02       Impact factor: 12.969

7.  Free tissue transfer and deep vein thrombosis.

Authors:  Dylan J Murray; Peter C Neligan; Christine B Novak; Brent Howley; Jay S Wunder; Joan E Lipa
Journal:  J Plast Reconstr Aesthet Surg       Date:  2008-01-22       Impact factor: 2.740

8.  Incidence of hematoma complication with heparin venous thrombosis prophylaxis after TRAM flap breast reconstruction.

Authors:  Eric C Liao; Amir H Taghinia; Lisa P Nguyen; Janet H Yueh; James W May; Dennis P Orgill
Journal:  Plast Reconstr Surg       Date:  2008-04       Impact factor: 4.730

9.  Thromboembolism in high-risk aesthetic surgery: experience with 17 patients in a review of 3871 consecutive cases.

Authors:  Christopher K Patronella; Amado Ruiz-Razura; Germán Newall; Henry A Mentz; Monica L Arango; Tiravat Assavapokee; Jana L Siarski
Journal:  Aesthet Surg J       Date:  2008 Nov-Dec       Impact factor: 4.283

10.  Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study.

Authors:  Siân Sweetland; Jane Green; Bette Liu; Amy Berrington de González; Marianne Canonico; Gillian Reeves; Valerie Beral
Journal:  BMJ       Date:  2009-12-03
View more
  77 in total

1.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  A validated risk model to predict 90-day VTE events in postsurgical patients.

Authors:  Christopher J Pannucci; Sandra Laird; Justin B Dimick; Darrell A Campbell; Peter K Henke
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

3.  The effect of postoperative enoxaparin on risk for reoperative hematoma.

Authors:  Christopher J Pannucci; Christine Fisher Wachtman; George Dreszer; Steven H Bailey; Pamela R Portschy; Jennifer B Hamill; Keith M Hume; Ronald E Hoxworth; Loree K Kalliainen; J Peter Rubin; Andrea L Pusic; Edwin G Wilkins
Journal:  Plast Reconstr Surg       Date:  2012-01       Impact factor: 4.730

4.  Changing practice: implementation of a venous thromboembolism prophylaxis protocol at an academic medical center.

Authors:  Christopher J Pannucci; Reda M Jaber; Justin M Zumsteg; Vlad Golgotiu; Lisa M Spratke; Edwin G Wilkins
Journal:  Plast Reconstr Surg       Date:  2011-11       Impact factor: 4.730

5.  Stratifying the risk of venous thromboembolism in otolaryngology.

Authors:  Andrew G Shuman; Hsou Mei Hu; Christopher J Pannucci; Christopher R Jackson; Carol R Bradford; Vinita Bahl
Journal:  Otolaryngol Head Neck Surg       Date:  2012-01-18       Impact factor: 3.497

6.  A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting.

Authors:  Yun Bao; Gang Zhao; Shuli Qu; Tengbin Xiong; Xingxing Yao; Bin Wu
Journal:  Clin Drug Investig       Date:  2020-02       Impact factor: 2.859

Review 7.  Prevention of venous thromboembolism in gynecologic oncology surgery.

Authors:  Emma L Barber; Daniel L Clarke-Pearson
Journal:  Gynecol Oncol       Date:  2016-11-25       Impact factor: 5.482

8.  Procedure-specific venous thromboembolism prophylaxis: a paradigm from colectomy surgery.

Authors:  Peter K Henke; Shipra Arya; Chris Pannucci; Jim Kubus; Samantha Hendren; Michael Engelsbe; Darrell Campbell
Journal:  Surgery       Date:  2012-10       Impact factor: 3.982

9.  The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patients.

Authors:  Emma L Barber; Daniel L Clarke-Pearson
Journal:  Am J Obstet Gynecol       Date:  2016-04-27       Impact factor: 8.661

Review 10.  Venous thromboembolism following arthroscopic knee surgery: a current concepts review of incidence, prophylaxis, and preoperative risk assessment.

Authors:  William C Graham; David C Flanigan
Journal:  Sports Med       Date:  2014-03       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.